• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用积极手术方法实现重症肌无力无药物缓解。

Aggressive surgical approach for drug-free remission from myasthenia gravis.

作者信息

Fischer J E, Grinvalski H T, Nussbaum M S, Sayers H J, Cole R E, Samaha F J

出版信息

Ann Surg. 1987 May;205(5):496-503. doi: 10.1097/00000658-198705000-00007.

DOI:10.1097/00000658-198705000-00007
PMID:3579398
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1493029/
Abstract

A series of 27 patients with generalized myasthenia gravis is presented. All patients were treated by a sternal split and extended thymectomy and radical mediastinal dissection. The overall drug-free remission rate was 63%, although three additional patients are likely to achieve drug-free remission in the near future, with the total drug-free remission rate then being 74%. Of the remaining patients, all but three improved and require decreased medication, for an improvement rate of approximately 90%. One patient who has not improved had an invasive malignant thymoma. Drug-free remission was achieved in 46% of the male patients and in 82% of the female patients despite that the mean duration of disease was greater than 3.5 years. There was one serious complication, that of sterile sternal dehiscence. There was no mortality. The results suggest that an aggressive, radical surgical approach to myasthenia gravis, even in a group of patients considered somewhat less favorable because of a relatively long duration of disease, can result in a high percentage of drug-free remissions. Radical surgery for myasthenia gravis appears to be the treatment of choice, with medical therapy being reserved for those patients who are not likely to survive operation.

摘要

本文报告了27例全身型重症肌无力患者。所有患者均接受胸骨劈开扩大胸腺切除术及根治性纵隔清扫术。总体无药缓解率为63%,另外3例患者近期可能实现无药缓解,届时总无药缓解率将达74%。其余患者中,除3例未改善外,均有好转且所需药物剂量减少,改善率约为90%。1例未改善的患者患有侵袭性恶性胸腺瘤。尽管平均病程超过3.5年,但男性患者的无药缓解率为46%,女性患者为82%。发生了1例严重并发症,即无菌性胸骨裂开。无死亡病例。结果表明,对于重症肌无力,即使是一组因病程相对较长而被认为预后稍差些的患者,积极的根治性手术方法也可导致高比例的无药缓解。重症肌无力的根治性手术似乎是首选治疗方法,药物治疗则保留给那些手术可能无法存活的患者。

相似文献

1
Aggressive surgical approach for drug-free remission from myasthenia gravis.采用积极手术方法实现重症肌无力无药物缓解。
Ann Surg. 1987 May;205(5):496-503. doi: 10.1097/00000658-198705000-00007.
2
Management of myasthenia gravis by extended thymectomy with anterior mediastinal dissection.扩大胸腺切除术联合前纵隔清扫术治疗重症肌无力
Surgery. 1992 Oct;112(4):681-7; discussion 687-8.
3
"Maximal" thymectomy for myasthenia gravis. Results.重症肌无力的“最大程度”胸腺切除术。结果
J Thorac Cardiovasc Surg. 1988 May;95(5):747-57.
4
[Trans-sternal thymectomy in myasthenia gravis].[重症肌无力的经胸骨胸腺切除术]
Chirurg. 1991 Jun;62(6):474-8.
5
Transsternal thymectomy for myasthenia gravis: surgical outcome.经胸骨胸腺切除术治疗重症肌无力:手术结果
Ann Thorac Surg. 2006 Jan;81(1):305-8. doi: 10.1016/j.athoracsur.2005.07.050.
6
Thymectomy for myasthenia gravis.重症肌无力的胸腺切除术
Am J Surg. 1983 Jul;146(1):61-6. doi: 10.1016/0002-9610(83)90260-x.
7
Thymoma following transcervical thymectomy for myasthenia gravis.重症肌无力经颈胸腺切除术后发生胸腺瘤
Ann Thorac Surg. 1983 May;35(5):548-50. doi: 10.1016/s0003-4975(10)60432-8.
8
[Trans-sternal thymectomy in myasthenia gravis and thymoma].[重症肌无力与胸腺瘤的经胸骨胸腺切除术]
Zentralbl Chir. 1995;120(12):963-8.
9
Long-term effects of infrasternal mediastinoscopic thymectomy in myasthenia gravis.胸骨后纵隔镜胸腺切除术治疗重症肌无力的长期疗效。
J Neurol Sci. 2009 Dec 15;287(1-2):185-7. doi: 10.1016/j.jns.2009.08.002. Epub 2009 Sep 2.
10
Safety for preoperative use of steroids for transsternal thymectomy in myasthenia gravis.重症肌无力经胸骨胸腺切除术前使用类固醇的安全性。
Eur J Cardiothorac Surg. 2004 Aug;26(2):407-11. doi: 10.1016/j.ejcts.2004.01.037.

引用本文的文献

1
Extended cervicomediastinal thymectomy in the integrated management of myasthenia gravis.扩大颈纵隔胸腺切除术在重症肌无力综合治疗中的应用
Ann Surg. 1997 Sep;226(3):324-34; discussion 334-5. doi: 10.1097/00000658-199709000-00012.

本文引用的文献

1
MYASTHENIA GRAVIS AND TUMORS OF THE THYMIC REGION: REPORT OF A CASE IN WHICH THE TUMOR WAS REMOVED.重症肌无力与胸腺区域肿瘤:一例肿瘤切除病例报告
Ann Surg. 1939 Oct;110(4):544-61. doi: 10.1097/00000658-193910000-00005.
2
AN ELECTROPHYSIOLOGICAL INVESTIGATION OF NEUROMUSCULAR TRANSMISSION IN MYASTHENIA GRAVIS.重症肌无力神经肌肉传递的电生理研究
J Physiol. 1964 Nov;174(3):417-34. doi: 10.1113/jphysiol.1964.sp007495.
3
An evaluation of thymectomy in myasthenia gravis.重症肌无力胸腺切除术的评估
Brain. 1958 Mar;81(1):112-44. doi: 10.1093/brain/81.1.112.
4
Reoperation after transcervical thymectomy for myasthenia gravis.经颈部胸腺切除术后重症肌无力的再次手术
Neurology. 1982 Jan;32(1):83-5. doi: 10.1212/wnl.32.1.83.
5
A prospective study of thymectomy and serum acetylcholine receptor antibodies in myasthenia gravis.重症肌无力胸腺切除术与血清乙酰胆碱受体抗体的前瞻性研究
Ann Surg. 1982 Aug;196(2):113-21. doi: 10.1097/00000658-198208000-00001.
6
Thymectomy for myasthenia gravis.重症肌无力的胸腺切除术
Am J Surg. 1983 Jul;146(1):61-6. doi: 10.1016/0002-9610(83)90260-x.
7
Recurrence of thymic hyperplasia after thymectomy in myasthenia gravis. Its importance as a cause of failure of surgical treatment.
Am J Med. 1983 Jan;74(1):78-82. doi: 10.1016/0002-9343(83)91122-1.
8
Myasthenia gravis, thymectomy, and antiacetycholine receptor antibody.重症肌无力、胸腺切除术和抗乙酰胆碱受体抗体
J Neurol. 1980;224(1):9-15. doi: 10.1007/BF00313202.
9
Myasthenia gravis induced by monoclonal antibodies to acetylcholine receptors.抗乙酰胆碱受体单克隆抗体诱发的重症肌无力。
Nature. 1980 May 22;285(5762):238-40. doi: 10.1038/285238a0.
10
Studies in myasthenia gravis. Transcervical total thymectomy.
JAMA. 1969 Aug 11;209(6):906-10.